This is the
talk page for discussing improvements to the
COVID-19 vaccine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2, 3, 4, 5Auto-archiving period: 30 days |
The
contentious topics procedure applies to this page. This page is related to
COVID-19, broadly construed, which has been
designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
WikiProject COVID-19 consensus WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page.
To ensure you are viewing the current list, you may wish to . |
This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to multiple WikiProjects. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Daily pageviews of this article
A graph should have been displayed here but
graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at
pageviews.wmcloud.org |
Page notices, consensus, and readership | |||||
|
"In April 2021, Astrazeneca and the European Medicines Agency (EMA) updated their information for healthcare professionals about AZD1222."
Given this, could the article expand on what was meant by "causal relationship" between the vaccination and the occurrence of thrombosis? For even if the adverse reactions where said to be "very rare", by how much had they "exceeded what would be expected in the general population"? Also, could the EMA Statement be updated to include their last advice on vaccination and any risk of thrombosis? — Preceding unsigned comment added by 95.149.166.237 ( talk) 20:11, 19 November 2023 (UTC)
Sadly discovered this posted by a relative who doesn't like the vaccine, but it is concerning. [1] Doug Weller talk 10:03, 29 January 2024 (UTC)
This
edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
In the end of the section "Adverse Events", after the part with tinnitus, the following references could be added, showing no signs of an increased rate of lasting vestibular damage:
https://doi.org/10.1111/ene.15546 https://doi.org/10.1097/mao.0000000000003275
It could read like this: "Compared to pre-pandemic cohorts, no increased rate of lasting peripheral-vestibular damage has been shown in observational studies [ref 1, 2]." J.Q.G. ( talk) 07:42, 3 April 2024 (UTC)
This is the
talk page for discussing improvements to the
COVID-19 vaccine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2, 3, 4, 5Auto-archiving period: 30 days |
The
contentious topics procedure applies to this page. This page is related to
COVID-19, broadly construed, which has been
designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
WikiProject COVID-19 consensus WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page.
To ensure you are viewing the current list, you may wish to . |
This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to multiple WikiProjects. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Daily pageviews of this article
A graph should have been displayed here but
graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at
pageviews.wmcloud.org |
Page notices, consensus, and readership | |||||
|
"In April 2021, Astrazeneca and the European Medicines Agency (EMA) updated their information for healthcare professionals about AZD1222."
Given this, could the article expand on what was meant by "causal relationship" between the vaccination and the occurrence of thrombosis? For even if the adverse reactions where said to be "very rare", by how much had they "exceeded what would be expected in the general population"? Also, could the EMA Statement be updated to include their last advice on vaccination and any risk of thrombosis? — Preceding unsigned comment added by 95.149.166.237 ( talk) 20:11, 19 November 2023 (UTC)
Sadly discovered this posted by a relative who doesn't like the vaccine, but it is concerning. [1] Doug Weller talk 10:03, 29 January 2024 (UTC)
This
edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
In the end of the section "Adverse Events", after the part with tinnitus, the following references could be added, showing no signs of an increased rate of lasting vestibular damage:
https://doi.org/10.1111/ene.15546 https://doi.org/10.1097/mao.0000000000003275
It could read like this: "Compared to pre-pandemic cohorts, no increased rate of lasting peripheral-vestibular damage has been shown in observational studies [ref 1, 2]." J.Q.G. ( talk) 07:42, 3 April 2024 (UTC)